Log in
Enquire now
Biotheranostics

Biotheranostics

A biotechnology company developing molecular-based diagnostic, prognostic, and predictive medical tests designed to help healthcare practitioners treat cancer.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
AngelList URL
angel.co/company/bi...heranostics
B2X
B2B
B2B
0
CEO
‌
Kevin Thornal
0
Company Operating Status
Active
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...anostics
Date Incorporated
1996
Email Address
clientservices@biotheranostics.com
0
Fax Number
(800) 266-9607
0
Former CEO
Don Hardison
Don Hardison
Founded Date
2008
0
Full Address
9640 Towne Centre Dr. Suite 200 San Diego, CA 92121, USA
0
Industry
Healthcare
Healthcare
Therapeutics
Therapeutics
Theranostics
Theranostics
Diagnostic tools
Diagnostic tools
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Cancer
Cancer
Diagnosis
Diagnosis
Technology
Technology
Biology
Biology
•••
Investors
HealthQuest Capital
HealthQuest Capital
MVM
MVM
‌
MVM Life Science Partners
Evidity Health Capital
Evidity Health Capital
Latest Funding Type
‌
Venture round
LinkedIn URL
@company/biotheranostics
Location
San Diego
San Diego
0
Number of Employees (Ranges)
51 – 200
0
Patents Assigned (Count)
6
Phone Number
+18778866739
0
Total Funding Amount (USD)
32,000,000
Official Website
biotheranostics.com
Wellfound ID
biotheranostics

Find more companies like Biotheranostics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.